NHS England approves new treatment for advanced ovarian cancer

4 Jun 2026 · Originally published 3 Jun 2026 9/10 Original headline: Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

Hundreds of women with chemotherapy-resistant ovarian cancer will now have access to a new life-prolonging drug called Elahere. This marks the first significant breakthrough for this type of cancer in over 20 years, offering patients much-needed hope and more time with their families.

Source: The Guardian UK National

Read the full story

About the AI positivity score

Report this article

Get your regular dose of good news

Follow the best stories on Bluesky or subscribe with your favourite feed reader.

Follow on Bluesky Subscribe via RSS

How AI positivity scores work

Scores out of ten are AI estimates of how uplifting a story is, not a measure of accuracy or importance. Different readers may feel differently. Headlines and summaries are AI-written; follow the source link for the original reporting.

How stories are selected